Related Experiment Video

Updated: Jun 13, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Clinical profile of cutaneous tuberculosis in pediatric age

S Kathuria1, V Ramesh

  • 1Safdarjung Hospital, New Delhi, India. drsushruta@gmail.com

Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|May 15, 2010
PubMed

Insights

Childhood cutaneous tuberculosis is a common pediatric skin condition. Early diagnosis and treatment with a short-course antitubercular regimen are crucial to prevent deformities and systemic spread.

Area of Science:

  • Pediatrics
  • Dermatology
  • Infectious Diseases

Background:

  • Childhood cutaneous tuberculosis (TB) is prevalent but understudied.
  • Specific forms like miliary TB, gumma, and tubercular chancre are more common in children than adults.
  • Immature immune systems increase the risk of systemic TB in children.

Purpose of the Study:

  • To highlight the unique aspects of childhood cutaneous tuberculosis.
  • To emphasize the importance of early diagnosis and prompt treatment.
  • To discuss management of residual deformities.

Main Methods:

  • Review of clinical presentations and common forms of childhood cutaneous TB.
  • Discussion of standard short-course antitubercular chemotherapy.
  • Consideration of preventive strategies for deformities.

Main Results:

  • Certain TB forms are more frequent in children.
  • Early diagnosis prevents complications and deformities.
  • Systemic evaluation is essential due to immune immaturity.

Conclusions:

  • Prompt diagnosis and treatment of childhood cutaneous TB are vital.
  • Effective management includes antitubercular regimens and addressing deformities.
  • Further research is needed for this understudied area.

More Related Videos

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo11:17

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

Published on: August 11, 2018

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...